Viewing Study NCT02676895


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2026-01-26 @ 1:41 PM
Study NCT ID: NCT02676895
Status: COMPLETED
Last Update Posted: 2019-02-18
First Post: 2016-02-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Shigella Sonnei Infection View
Keywords: